![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 27, 16874-16879, July 3, 1998
,
,
,
,
From the Activating transcription factor 1 (ATF1) and
cAMP-responsive element (CRE)-binding protein (CREB) activate
transcription through CREs located in the promoters of cellular and
viral genes. We previously described a monoclonal antibody (mAb41.4)
that prevents ATF1 binding to DNA and reduces CRE-driven promoter
activity in vitro (Orten, D. J., Strawhecker, J. M., Sanderson, S. D., Huang, D., Prytowsky, M. B., and
Hinrichs, S. H. (1994) J. Biol. Chem. 269, 32254-32263). A single chain Fv (scFv) fragment from the mAb41.4-expressing hybridoma was generated to provide a means to
investigate transcription factor function via intracellular expression
of the scFv fragment. The affinity of scFv4 (subgroup: VL
Department of Pathology and Microbiology,
University of Nebraska Medical Center, Omaha, Nebraska 68198-6495, the ** Department of Biochemistry, University of Bath, Bath BA2 7AY,
United Kingdom, and the
Department of Pathology and Laboratory
Medicine, University of Texas Health Sciences Center,
Houston, Texas 77030
-III, VH miscellaneous) for ATF1 was similar to that of
the parental mAb and the Fab fragment, but it demonstrated greater inhibitory activity and reacted with CREB. scFv4 disrupted the binding
of both ATF1 and CREB in electrophoretic mobility shift assays and
reduced expression of CRE-driven expression in vitro. Transient expression of scFv had no effect on the non-CRE-containing adenovirus major late promoter. The proliferating cell nuclear antigen
promoter, containing two CREs, was significantly more sensitive to
inhibition by scFv than the cytomegalovirus immediate-early promoter,
containing five CREs. Cotransfection of either ATF1 or CREB in the
presence of scFv restored basal levels of expression. The intracellular
expression of scFv provides a unique means to investigate the roles of
the transcription factors ATF1 and CREB.
This article has been cited by other articles:
![]() |
J. M. Bosilevac, R. J. Olsen, J. A. Bridge, and S. H. Hinrichs Tumor Cell Viability in Clear Cell Sarcoma Requires DNA Binding Activity of the EWS/ATF1 Fusion Protein J. Biol. Chem., December 3, 1999; 274(49): 34811 - 34818. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |